Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease

J Mol Neurosci. 2004;24(3):337-42. doi: 10.1385/JMN:24:3:337.

Abstract

Lewy body disease (LBD) refers to a heterogeneous group of disorders presenting with parkinsonism and Lewy body (LB) formation. Although the relationship between dementing syndromes with LBs, Parkinson's disease, and Alzheimer's disease is unclear, the former constitute a common form of degenerative dementia and may account for up to 20% of cases in the elderly. We recently demonstrated triplication of the alpha-synuclein gene as the cause of disease in the Spellman-Muenter kindred. Neuropathological examination of affected members of the kindred demonstrated extensive LB pathology consistent with diffuse LBD. We examined a large collection of pathologically confirmed LBD cases and found no evidence for multiplication of the alpha-synuclein gene, suggesting that this mechanism is not a common cause of LBD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Brain / metabolism*
  • Brain / pathology
  • Brain / physiopathology
  • Brain Chemistry / genetics*
  • Gene Dosage*
  • Genomic Instability / genetics
  • Humans
  • Lewy Bodies / genetics
  • Lewy Bodies / metabolism
  • Lewy Bodies / pathology
  • Lewy Body Disease / genetics*
  • Lewy Body Disease / metabolism*
  • Lewy Body Disease / physiopathology
  • Nerve Tissue Proteins / genetics*
  • Neurons / metabolism
  • Neurons / pathology
  • Synucleins
  • alpha-Synuclein

Substances

  • Nerve Tissue Proteins
  • SNCA protein, human
  • Synucleins
  • alpha-Synuclein